New Zealand markets closed
  • NZX 50

    -19.78 (-0.18%)

    +0.0047 (+0.74%)

    +24.40 (+0.33%)
  • OIL

    -0.21 (-0.18%)
  • GOLD

    +8.90 (+0.49%)

AbCellera to Report Full Year 2021 Financial Results on February 24, 2022

·1-min read

VANCOUVER, British Columbia, January 27, 2022--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market close on Thursday, February 24, 2022 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.

The live webcast of the earnings conference will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.

About AbCellera Biologics Inc.

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit

Source: AbCellera Biologics Inc.

View source version on


Media: Jessica Yingling, Ph.D.;, +1(236)521-6774
Investor Relations: Melanie Solomon;, +1(778)729-9116

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting